4 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Bortezomib: new trials by email Literature Review of Bortezomib trials Research Report on Bortezomib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bortezomib for Treating Glomerular Diseases Bortezomib - Bortezomib, Glomerulonephritis | Not applicable | Unknown | Ruijin Hospital | 20 | 2022-08-02 | 2022-10-31 |
| Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML DAG pre-excitation regimen with Bortezomib - Bortezomib, Acute Myeloid Leukemia | Phase 1 | Unknown | Zhongnan Hospital | 40 | 2020-01-01 | 2023-08-09 |
| Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics Bortezomib - Multiple Myeloma, Bortezomib | Unknown | Beijing Chao Yang Hospital | 350 | 2019-05-16 | 2022-04-28 | |
| Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma G-CSF, Bortezomib, Cyclophosphamide - Myeloma, Bortezomib | Phase 2 | Unknown | Second Affiliated Hospital of Soochow University | 60 | 2013-12-01 | 2014-01-06 |
Glomerulonephritis (1) · Glomerulonephritis, IGA (1) · Leukemia, Myeloid, Acute (1) · Multiple Myeloma (1) · Neoplasms, Plasma Cell (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Autoimmune Diseases (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immunoproliferative Disorders (1) · Kidney Diseases (1) · Leukemia (1)
Bortezomib (4) · Cyclophosphamide (1) · Dexamethasone (1) · Granulocyte Colony-Stimulating Factor (1)
Beijing Chao Yang Hospital (1) · Ruijin Hospital (1) · Second Affiliated Hospital of Soochow University (1) · Zhongnan Hospital (1)
China (4)
Fuling Zhou, phD (1) · Jinxiang Fu, M.D., PhD (1) · Lihong Liu, Doctor (1)